QIAGEN Reports Results for First Quarter 2015

Go back to QIAGEN Reports Results for First Quarter 2015

Qiagen (QGEN) Reports In-Line Q1 EPS; Reaffirms

May 5, 2015 4:28 PM EDT

Qiagen (NASDAQ: QGEN) reported Q1 EPS of $0.22, in-line with the analyst estimate of $0.22. Revenue for the quarter came in at $298.7 million versus the consensus estimate of $304.6 million.

2015 outlook

QIAGEN reaffirms its expectations to deliver higher CER adjusted net sales and adjusted earnings in 2015, as above-market sales growth from the current core portfolio - led by the growth drivers - well exceeds the final year of significant headwinds from reduced U.S. sales of HPV products. These expectations do not take into account any further acquisitions that could be... More